1-5 of 5
end organ damage
Close
Sort by
Journal Articles

Impact of sickle cell trait on morbidity and mortality from SARS-CoV-2 infection

Clinical Trials & Observations
Lauren E. Merz, Kavita Mistry, Donna Neuberg, Revital Freedman, Gerda Menard, David M. Dorfman, Hae Soo Park, Katherine Jolley, Maureen O. Achebe
Journal: Blood Advances
Blood Adv (2021) 5 (18): 3690–3693.
https://doi.org/10.1182/bloodadvances.2021004977
Published: 2021
Journal Articles

Curative vs targeted therapy for SCD: does it make more sense to address the root cause than target downstream events?

Clinical Trials & Observations
Marilyn J. Telen
Journal: Blood Advances
Blood Adv (2020) 4 (14): 3457–3465.
https://doi.org/10.1182/bloodadvances.2020001469
Published: 2020
Journal Articles

Role of the coagulation system in the pathogenesis of sickle cell disease

Md Nasimuzzaman, Punam Malik
Journal: Blood Advances
Blood Adv (2019) 3 (20): 3170–3180.
https://doi.org/10.1182/bloodadvances.2019000193
Published: 2019
Journal Articles

Pathophysiology and management of monoclonal gammopathy of renal significance

Clinical Trials & Observations
Ankur Jain, Richard Haynes, Jaimal Kothari, Akhil Khera, Maria Soares, Karthik Ramasamy
Journal: Blood Advances
Blood Adv (2019) 3 (15): 2409–2423.
https://doi.org/10.1182/bloodadvances.2019031914
Published: 2019
Includes: Supplemental data
Journal Articles

Toward dual hematopoietic stem-cell transplantation and solid-organ transplantation for sickle-cell disease

Hitomi Hosoya, Jeffrey Levine, Peter Abt, David Henry, David L. Porter, Saar Gill
Journal: Blood Advances
Blood Adv (2018) 2 (5): 575–585.
https://doi.org/10.1182/bloodadvances.2017012500
Published: 2018